BACKGROUND: Previous studies by different authors have reported their readmission rates after pancreatectomy as either “30 days from discharge” or “90 days from surgery.” The objective of this study was to determine which of these definitions captures the most surgery-related complications. METHODS: A prospectively maintained database at a high volume center was queried to identify all individuals who underwent pancreatectomy between 2000 and 2012 for any diagnosis. The data was analyzed at 30 days after discharge and 90 days after operation. The optimal timing for complication reporting was defined as the time point that maximized the capture of surgery-related readmissions and direct major surgical complications while minimizing the capture of disease (cancer)-related readmissions. RESULTS: There were 1123 patients included during the study time period. The median age was 63 years old, and 55.6% were male. Operations included 833 (74.2%) pancreaticoduodenectomies, 257 (22.9%) distal pancreatectomies, 18 (1.6%) total pancreatectomies, and 15 (1.3%) central pancreatectomies. Surgery-related readmissions occurred in 248 (22%) individuals, while readmission related to malignant disease progression occurred in 25 (2%) individuals. The 30 days from discharge definition captured 184 surgery-related readmissions and 1 disease-related readmission (sensitivity 0.74, specificity 0.96). The 90 days from surgery definition captured 215 surgery-related readmissions and 1 disease-related readmission (sensitivity 0.87, specificity 0.96). Major surgical complication was the only independent factor associated with readmission not captured by the 30 days from discharge definition (p = 0.002, HR 3.94, 95% CI 1.44–12.22). CONCLUSION: The 90 days from surgery definition was superior to the 30 days from discharge definition, especially with regards to readmission related to major surgical complications.
BACKGROUND: Previous studies by different authors have reported their readmission rates after pancreatectomy as either “30 days from discharge” or “90 days from surgery.” The objective of this study was to determine which of these definitions captures the most surgery-related complications. METHODS: A prospectively maintained database at a high volume center was queried to identify all individuals who underwent pancreatectomy between 2000 and 2012 for any diagnosis. The data was analyzed at 30 days after discharge and 90 days after operation. The optimal timing for complication reporting was defined as the time point that maximized the capture of surgery-related readmissions and direct major surgical complications while minimizing the capture of disease (cancer)-related readmissions. RESULTS: There were 1123 patients included during the study time period. The median age was 63 years old, and 55.6% were male. Operations included 833 (74.2%) pancreaticoduodenectomies, 257 (22.9%) distal pancreatectomies, 18 (1.6%) total pancreatectomies, and 15 (1.3%) central pancreatectomies. Surgery-related readmissions occurred in 248 (22%) individuals, while readmission related to malignant disease progression occurred in 25 (2%) individuals. The 30 days from discharge definition captured 184 surgery-related readmissions and 1 disease-related readmission (sensitivity 0.74, specificity 0.96). The 90 days from surgery definition captured 215 surgery-related readmissions and 1 disease-related readmission (sensitivity 0.87, specificity 0.96). Major surgical complication was the only independent factor associated with readmission not captured by the 30 days from discharge definition (p = 0.002, HR 3.94, 95% CI 1.44–12.22). CONCLUSION: The 90 days from surgery definition was superior to the 30 days from discharge definition, especially with regards to readmission related to major surgical complications.
Authors: Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-11 Impact factor: 3.452
Authors: Lisa Keeping-Burke; Margaret Purden; Nancy Frasure-Smith; Sylvie Cossette; Frank McCarthy; Rhonda Amsel Journal: Res Nurs Health Date: 2013-11-08 Impact factor: 2.228
Authors: Irene Epelboym; Irmina Gawlas; James A Lee; Beth Schrope; John A Chabot; John D Allendorf Journal: World J Surg Date: 2014-06 Impact factor: 3.352
Authors: Michael L Johnson; Howard S Gordon; Nancy J Petersen; Nelda P Wray; A Laurie Shroyer; Frederick L Grover; Jane M Geraci Journal: Med Care Date: 2002-01 Impact factor: 2.983
Authors: Zachary J Kastenberg; John M Morton; Brendan C Visser; Jeffrey A Norton; George A Poultsides Journal: HPB (Oxford) Date: 2012-09-24 Impact factor: 3.647
Authors: Deepa Magge; William Gooding; Haroon Choudry; Jennifer Steve; Jennifer Steel; Amer Zureikat; Alyssa Krasinskas; Mustapha Daouadi; Kenneth K W Lee; Steven J Hughes; Herbert J Zeh; A James Moser Journal: JAMA Surg Date: 2013-06 Impact factor: 14.766
Authors: Eric B Schneider; Omar Hyder; Christopher L Wolfgang; Kenzo Hirose; Michael A Choti; Martin A Makary; Joseph M Herman; John L Cameron; Timothy M Pawlik Journal: J Am Coll Surg Date: 2012-08-24 Impact factor: 6.113
Authors: Aaron J Dawes; Greg D Sacks; Marcia M Russell; Anne Y Lin; Melinda Maggard-Gibbons; Deborah Winograd; Hallie R Chung; Areti Tillou; Jonathan R Hiatt; Clifford Ko Journal: J Am Coll Surg Date: 2014-04-13 Impact factor: 6.113
Authors: Irina Yermilov; David Bentrem; Evan Sekeris; Sushma Jain; Melinda A Maggard; Clifford Y Ko; James S Tomlinson Journal: Ann Surg Oncol Date: 2008-11-11 Impact factor: 5.344
Authors: Sushanth Reddy; Carlo M Contreras; Brandon Singletary; T Miller Bradford; Mary G Waldrop; Andrew H Mims; W Andrew Smedley; Jacob A Swords; Thomas N Wang; Martin J Heslin Journal: J Am Coll Surg Date: 2016-01-28 Impact factor: 6.113